Sarepta Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$116.9M
Doctors Paid
1,587
Transactions
21,423
2024 Total
$17.2M
Payment Breakdown by Category
Research$103.9M (88.9%)
Consulting$6.0M (5.1%)
Royalty/License$4.5M (3.8%)
Travel$927,060 (0.8%)
Food & Beverage$193,459 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $103.9M | 13,971 | 88.9% |
| Consulting Fee | $6.0M | 1,201 | 5.1% |
| Royalty or License | $4.5M | 64 | 3.8% |
| Grant | $1.2M | 53 | 1.0% |
| Travel and Lodging | $927,060 | 1,773 | 0.8% |
| Food and Beverage | $193,459 | 4,224 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $137,054 | 75 | 0.1% |
| Education | $16,385 | 60 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $2,545 | 2 | 0.0% |
Payments by Type
Research
$103.9M
13,971 transactions
General
$13.0M
7,452 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| 4045-301 | $21.0M | 3 | 903 |
| 4658-301 | $13.0M | 0 | 501 |
| SRP-9001-301 | $12.3M | 0 | 5,501 |
| SRP-9001-102 | $5.8M | 1 | 139 |
| SRP-9001-103 | $5.7M | 2 | 1,213 |
| SRP-5051-201 | $3.0M | 0 | 211 |
| SRP-9001-303 | $3.0M | 15 | 2,164 |
| Nationwide SRA | $3.0M | 0 | 14 |
| 4658-203 | $2.2M | 0 | 90 |
| 5051-201 | $1.9M | 1 | 141 |
| 4658-402 | $1.7M | 1 | 225 |
| 9001-102 | $1.5M | 0 | 10 |
| SRP-9001-305 | $1.3M | 0 | 833 |
| 4658-403 | $1.3M | 0 | 538 |
| 4045-101 | $1.2M | 2 | 57 |
| 4658-202 | $1.2M | 0 | 72 |
| 5051-102 | $1.2M | 0 | 206 |
| Research Institute at Nationwide SRA | $1.1M | 0 | 6 |
| 4658-204 | $986,509 | 0 | 43 |
| Leveraging large-scale genomic and clinical data to characterize rare, pathogenic mutations associated with dilated cardiomyopathy | $919,598 | 0 | 3 |
| SRP-LGMD-501-NHS | $916,841 | 0 | 131 |
| SRP-9003-301 | $898,996 | 1 | 91 |
| Sponsored Research Agreement - DMD | $852,155 | 0 | 31 |
| SRP-9003-102 | $613,033 | 0 | 37 |
| Phase IV Golodirsen | $595,541 | 0 | 4 |
| SRA with Duke for exosome gene editing | $563,500 | 0 | 2 |
| TESTING SARCOSPAN AS A THERAPEUTIC AND BIOMARKER FOR SARCOGLYCA | $487,797 | 0 | 3 |
| Powell Gene Therapy | $479,977 | 0 | 3 |
| Gene therapy approach to treat arrhythmias using MYBPC3 | $445,069 | 0 | 2 |
| Sponsored Research Agreement - CMT | $430,473 | 0 | 20 |
Payments by Medical Specialty
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Willis Maddrey, Md, MD | Hepatology | Dallas, TX | $10,958 | $0 |
| Arpita Lakhotia, Md, MD | Clinical Neurophysiology | Owensboro, KY | $10,897 | $0 |
| Eric Strong | Internal Medicine | Danville, PA | $10,756 | $0 |
| M Mccormick, D.o, D.O | Neurology with Special Qualifications in Child Neurology | Farmington Hills, MI | $10,682 | $0 |
| Ms. Natalie Goedeker, Pnp, PNP | Pediatrics | Saint Louis, MO | $10,487 | $0 |
| Miguel Chuquilin, M.d, M.D | Neurology | Tallahassee, FL | $10,232 | $0 |
| Barry Russman, Md, MD | Neurology with Special Qualifications in Child Neurology | Portland, OR | $10,208 | $0 |
| Dr. Carla Grosmann, M.d, M.D | Neuromuscular Medicine | Saint Paul, MN | $10,181 | $0 |
| Dr. Michio Hirano, M.d, M.D | Neurology | New York, NY | $10,136 | $0 |
| Dr. Ratna Bhavaraju-Sanka, M.d, M.D | Neurology | San Antonio, TX | $10,133 | $0 |
| Larry Kwak, M.d. , Phd, M.D. , PHD | Medical Oncology | Duarte, CA | $10,000 | $0 |
| James Udelson, M.d, M.D | Cardiovascular Disease | Boston, MA | $10,000 | $0 |
| Fawn Leigh, Md, MD | Pediatrics | Seattle, WA | $9,954 | $0 |
| Jennifer Shifflet, Pa-C, PA-C | Physician Assistant | Phoenix, AZ | $9,484 | $0 |
| Clara Chow Haws, M.d, M.D | Student in an Organized Health Care Education/Training Program | Phoenix, AZ | $9,433 | $0 |
| Dr. David Greenburg, M.d, M.D | Internal Medicine | Arnold, MD | $9,250 | $0 |
| William Burnette, Md, MD | Neuromuscular Medicine | Nashville, TN | $9,238 | $0 |
| Dr. Gregory Burkhart, M.d, M.D | Public Health & General Preventive Medicine | Reston, VA | $9,150 | $0 |
| Dr. Vovanti Jones, M.d, M.D | Physical Medicine & Rehabilitation | Columbia, MO | $9,011 | $0 |
| Dr. Jeffrey Zitsman, M.d, M.D | Pediatric Surgery | New York, NY | $9,000 | $0 |
| Daniel Guillen Mendoza, M.d, M.D | Neurology with Special Qualifications in Child Neurology | Memphis, TN | $8,990 | $0 |
| Dr. Mathula Thangarajh, Md, Phd, MD, PHD | Neurology with Special Qualifications in Child Neurology | Richmond, VA | $8,486 | $0 |
| Kathleen Schwarz, M.d, M.D | Pediatrics | San Diego, CA | $8,400 | $0 |
| Dr. Kumaraswamy Sivakumar, M.d, M.D | Specialist | Phoenix, AZ | $8,319 | $0 |
| Samantha Weaver, Msn, Pnp-Ac, MSN, PNP-AC | Nurse Practitioner | Birmingham, AL | $8,255 | $0 |
Ad
Top Products
- EXONDYS 51 $10.8M
- Exondys 51 $6.1M
Associated Products (5)
- EXONDYS 51 $10.8M
- Exondys 51 $6.1M
- Amondys 45 $4.8M
- Vyondys 53 $2.8M
- Elevidys $377,981
Payment Categories
- Food & Beverage $193,459
- Consulting $6.0M
- Travel & Lodging $927,060
- Research $103.9M
- Royalties $4.5M
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. has made $116.9M in payments to 1,587 healthcare providers, recorded across 21,423 transactions in the CMS Open Payments database. In 2024, the company paid $17.2M. The top product by payment volume is EXONDYS 51 ($10.8M).
Payments were distributed across 101 medical specialties. The top specialty by payment amount is Neurology with Special Qualifications in Child Neurology ($2.0M to 155 doctors).
Payment categories include: Food & Beverage ($193,459), Consulting ($6.0M), Research ($103.9M), Travel & Lodging ($927,060), Royalties ($4.5M).
Sarepta Therapeutics, Inc. is associated with 5 products in the CMS Open Payments database, including EXONDYS 51, Exondys 51, and Amondys 45.